Advertisement
Screener

MEDICINOVA, INC. (MNOV) Increase (Decrease) in Employee Related Liabilities

2.8 / 5 stars · 68/120 Roast Me

MEDICINOVA, INC. Increase (Decrease) in Employee Related Liabilities

MEDICINOVA, INC. (MNOV) reported Increase (Decrease) in Employee Related Liabilities of -$314.12 thousand for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-07-26.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2016-07-26

  • MEDICINOVA, INC. increase (decrease) in employee related liabilities for the quarter ending 2016-06-30 was $166.61K, a 39.73% increase year-over-year.
  • MEDICINOVA, INC. increase (decrease) in employee related liabilities for the quarter ending 2016-03-31 was -$480.73K.
  • MEDICINOVA, INC. increase (decrease) in employee related liabilities for the quarter ending 2015-12-31 was $268.22K, a 11.28% increase year-over-year.
  • MEDICINOVA, INC. increase (decrease) in employee related liabilities for the quarter ending 2015-09-30 was $125.67K, a 4.16% increase year-over-year.
  • MEDICINOVA, INC. increase (decrease) in employee related liabilities for fiscal 2015 was $72.66K, a 87.89% decline from fiscal 2014.
  • MEDICINOVA, INC. increase (decrease) in employee related liabilities for fiscal 2014 was $600.10K.
  • MEDICINOVA, INC. increase (decrease) in employee related liabilities for fiscal 2013 was -$41.73K.
  • MEDICINOVA, INC. increase (decrease) in employee related liabilities for fiscal 2012 was -$370.96K, a 248.19% decline from fiscal 2011.
Period endIncrease (Decrease) in Employee Related Liabilities 3 monthIncrease (Decrease) in Employee Related Liabilities 6 monthIncrease (Decrease) in Employee Related Liabilities 9 monthIncrease (Decrease) in Employee Related Liabilities 12 monthIncrease (Decrease) in Employee Related Liabilities 129 monthIncrease (Decrease) in Employee Related Liabilities 132 monthIncrease (Decrease) in Employee Related Liabilities 135 monthIncrease (Decrease) in Employee Related Liabilities 138 monthIncrease (Decrease) in Employee Related Liabilities 141 monthIncrease (Decrease) in Employee Related Liabilities 144 monthIncrease (Decrease) in Employee Related Liabilities 147 monthIncrease (Decrease) in Employee Related Liabilities 150 monthIncrease (Decrease) in Employee Related Liabilities 153 monthIncrease (Decrease) in Employee Related Liabilities 156 month
2016-06-30$166.61K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-26
-$314.12K
10-Q · filed 2016-07-26
-$45.89K
derived: sum of 3 quarters · filed 2016-07-26
$79.78K
derived: sum of 4 quarters · filed 2016-07-26
2016-03-31-$480.73K
10-Q · filed 2016-04-27
-$212.50K
derived: sum of 2 quarters · filed 2016-04-27
-$86.83K
derived: sum of 3 quarters · filed 2016-04-27
$32.40K
derived: sum of 4 quarters · filed 2016-07-26
2015-12-31$268.22K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25
$393.89K
derived: sum of 2 quarters · filed 2016-02-25
$513.13K
derived: sum of 3 quarters · filed 2016-07-26
$72.66K
10-K · filed 2016-02-25
2015-09-30$125.67K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29
$244.90K
derived: sum of 2 quarters · filed 2016-07-26
-$195.57K
10-Q · filed 2015-10-29
$45.47K
derived: sum of 4 quarters · filed 2016-07-26
2015-06-30$119.23K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-26
-$321.24K
10-Q · filed 2016-07-26
-$80.20K
derived: sum of 3 quarters · filed 2016-07-26
$40.45K
derived: sum of 4 quarters · filed 2016-07-26
2015-03-31-$440.47K
10-Q · filed 2016-04-27
-$199.43K
derived: sum of 2 quarters · filed 2016-04-27
-$78.78K
derived: sum of 3 quarters · filed 2016-04-27
$33.82K
derived: sum of 4 quarters · filed 2016-04-27
2014-12-31$241.04K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25
$361.69K
derived: sum of 2 quarters · filed 2016-02-25
$474.29K
derived: sum of 3 quarters · filed 2016-02-25
$600.10K
10-K · filed 2016-02-25
2014-09-30$120.65K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29
$233.25K
derived: sum of 2 quarters · filed 2015-10-29
$359.06K
10-Q · filed 2015-10-29
$105.37K
derived: sum of 4 quarters · filed 2015-10-29
2014-06-30$112.60K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30
$238.41K
10-Q · filed 2015-07-30
-$15.28K
derived: sum of 3 quarters · filed 2015-07-30
-$66.00K
derived: sum of 4 quarters · filed 2015-07-30
2014-03-31$125.81K
10-Q · filed 2015-05-11
-$127.88K
derived: sum of 2 quarters · filed 2015-05-11
-$178.60K
derived: sum of 3 quarters · filed 2015-05-11
$65.87K
derived: sum of 4 quarters · filed 2015-05-11
2013-12-31-$253.69K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
-$304.42K
derived: sum of 2 quarters · filed 2015-03-12
-$59.94K
derived: sum of 3 quarters · filed 2015-03-12
-$41.73K
10-K · filed 2015-03-12
2013-09-30-$50.72K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13
$193.75K
derived: sum of 2 quarters · filed 2014-11-13
$211.96K
10-Q · filed 2014-11-13
$236.96K
derived: sum of 4 quarters · filed 2014-11-13
$343.94K
10-Q · filed 2013-11-07
2013-06-30$244.48K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13
$262.69K
10-Q · filed 2014-08-13
$287.68K
derived: sum of 3 quarters · filed 2014-08-13
$281.49K
derived: sum of 4 quarters · filed 2014-08-13
$394.67K
10-Q · filed 2013-08-08
2013-03-31$18.21K
10-Q · filed 2014-05-08
$43.20K
derived: sum of 2 quarters · filed 2014-05-08
$37.02K
derived: sum of 3 quarters · filed 2014-05-08
-$319.96K
derived: sum of 4 quarters · filed 2014-05-08
$150.19K
10-Q · filed 2013-05-08
2012-12-31$24.99K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27
$18.81K
derived: sum of 2 quarters · filed 2014-03-27
-$338.17K
derived: sum of 3 quarters · filed 2014-03-27
-$370.96K
10-K · filed 2014-03-27
$131.98K
10-K · filed 2013-03-28
2012-09-30-$6.19K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
-$363.16K
derived: sum of 2 quarters · filed 2013-11-07
-$395.96K
10-Q · filed 2013-11-07
-$261.84K
derived: sum of 4 quarters · filed 2013-11-07
$106.99K
10-Q · filed 2012-11-08
2012-06-30-$356.98K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08
-$389.77K
10-Q · filed 2013-08-08
-$255.66K
derived: sum of 3 quarters · filed 2013-08-08
-$224.71K
derived: sum of 4 quarters · filed 2013-08-08
$113.18K
10-Q · filed 2012-08-09
2012-03-31-$32.79K
10-Q · filed 2013-05-08
$101.32K
derived: sum of 2 quarters · filed 2013-05-08
$132.26K
derived: sum of 3 quarters · filed 2013-05-08
$64.28K
derived: sum of 4 quarters · filed 2013-05-08
$470.15K
10-Q · filed 2012-05-10
2011-12-31$134.12K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28
$165.06K
derived: sum of 2 quarters · filed 2013-03-28
$97.08K
derived: sum of 3 quarters · filed 2013-03-28
$250.33K
10-K · filed 2013-03-28
$502.95K
10-K · filed 2012-03-29
2011-09-30$30.94K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
-$37.04K
derived: sum of 2 quarters · filed 2012-11-08
$116.22K
10-Q · filed 2012-11-08
$203.67K
derived: sum of 4 quarters · filed 2012-11-08
$368.83K
10-Q · filed 2011-11-14
2011-06-30-$67.98K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$85.27K
10-Q · filed 2012-08-09
$172.73K
derived: sum of 3 quarters · filed 2012-08-09
$144.70K
derived: sum of 4 quarters · filed 2012-08-09
$337.89K
10-Q · filed 2011-08-15
2011-03-31$153.26K
10-Q · filed 2012-05-10
$240.71K
derived: sum of 2 quarters · filed 2012-05-10
$212.68K
derived: sum of 3 quarters · filed 2012-05-10
2010-12-31$87.45K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29
$59.43K
derived: sum of 2 quarters · filed 2012-03-29
-$798.21K
10-K · filed 2012-03-29
2010-09-30-$28.03K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
-$885.66K
10-Q · filed 2011-11-14
2010-06-30-$857.63K
10-Q · filed 2011-08-15
2009-12-31$285.67K
10-K · filed 2012-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
Atrium Therapeutics, Inc. (RNA)United States$0.140B